低体温治療システム市場 : 2028年までの世界予測

世界の低体温治療システム市場は、予測期間中に6.3%のCAGRで、2023年の2億9,100万米ドルから2028年までに3億9,600万米ドルに達すると予測されています。

MarketsandMarkets（マーケッツアンドマーケッツ）「低体温治療システム市場 : 製品 (冷却装置、冷却カテーテル、クールキャップ)、用途 (神経学、心臓病学、新生児ケア)、地域 (北米、ヨーロッパ、アジア太平洋、ROW) – 2028年までの世界予測 – Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) – Global Forecast to 2028」は世界の低体温治療（低体温療法／体温維持療法）システム市場を調査し、主要セグメント毎に分析・予測を行っています。

Report Overview

The global therapeutic hypothermia systems market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period.

The growth of this market is majorly driven by the growing prevalence of infectious and chronic diseases and the rise in the use of minimally invasive cooling methods. However, the presence of alternative methods and less awareness in developing countries could restrain the growth of the therapeutic hypothermia systems market.

“Cooling devices segment accounted for the highest market share in the therapeutic hypothermia systems market, by product, during the forecast period.”
Based on product, the therapeutic hypothermia systems market is classified into Cooling Catheters, Cooling devices and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the ease of use, fewer labor-intensive devices available, and the presence of a simple and effective thermal regulating system with the control unit.

“Cardiology accounted for the highest CAGR during the forecast period.”
Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The cardiology segment accounted for the highest CAGR of the therapeutic hypothermia systems market in 2022. The highest CAGR of this segment can be primarily attributed to the potential benefit of using hypothermia for treating cardiac arrest patients.

“The North America segment accounted for the highest market share in the therapeutic hypothermia systems market, by region, during the forecast period.”
Based on the region, the global therapeutic hypothermia systems market is categorized into North America, Asia Pacific, Europe, and the Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced therapeutic hypothermia systems products and the increasing advancement in the medical device industries are supporting the growth of the therapeutic hypothermia systems market.

Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Europe (30%), Asia-Pacific (34%), and RoW (15%)

Prominent companies include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), Gentherm Incorporated (US),  Belmont Medical Technologies (US), International Biomedical Ltd. (US), EM-MED (Poland), Phoenix Medical Systems (India), Life Recovery Systems (US), Shenzhen Comen Medical Instruments Co., Ltd. (China), MiraCradle (India), Terumo Cardiovascular Systems Corporation (US), pfm medical hico gmbh (Germany), VNG Medical Innovation System Pvt. Ltd. (India), Aspen Systems (US), CoolTech Medical (US), Global Healthcare SG (Singapore), Cryothermic Systems Incorporated (US), Paxman Coolers Ltd. (UK), Dignitana AB (Italy), and Wishcaps (US).

Research Coverage
This research report categorizes the therapeutic hypothermia systems market by product, application, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the therapeutic hypothermia systems market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the therapeutic hypothermia systems market. Competitive analysis of upcoming startups in the therapeutic hypothermia systems market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall therapeutic hypothermia systems market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the therapeutic hypothermia systems market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the therapeutic hypothermia systems market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the therapeutic hypothermia systems market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the therapeutic hypothermia systems market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), among others in the therapeutic hypothermia systems market strategies. 

Table of Contents

1            INTRODUCTION            25

1.1         STUDY OBJECTIVES      25

1.2         MARKET DEFINITION   25

1.2.1      INCLUSIONS & EXCLUSIONS OF STUDY 26

1.3         MARKET SCOPE             26

1.3.1      MARKETS COVERED     26

FIGURE 1           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION           26

1.3.2      YEARS CONSIDERED     27

1.4         CURRENCY        27

1.5         STAKEHOLDERS            27

1.6         LIMITATIONS   28

2            RESEARCH METHODOLOGY     29

2.1         RESEARCH DATA           29

FIGURE 2           RESEARCH DESIGN       29

2.1.1      SECONDARY DATA       30

2.1.1.1   Secondary sources             30

2.1.2      PRIMARY DATA 31

FIGURE 3           PRIMARY SOURCES       31

2.1.2.1   Key data from primary sources         32

2.1.2.2   Key industry insights          32

2.1.2.3   Breakdown of primary interviews     33

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    33

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION    33

2.2         MARKET SIZE ESTIMATION       34

2.2.1      APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH    34

FIGURE 6           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION              34

2.2.2      APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS              35

TABLE 1             REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS        35

2.2.3      APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS     35

2.2.4      APPROACH 4: PRIMARY INTERVIEWS    36

FIGURE 7           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   36

FIGURE 8           TOP-DOWN APPROACH             37

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          38

FIGURE 9           DATA TRIANGULATION METHODOLOGY         38

2.4         MARKET SHARE ANALYSIS         39

2.5         MARKET ASSUMPTIONS             39

2.6         RISK ASSESSMENT         39

TABLE 2             RISK ASSESSMENT         39

2.7         RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET            40

3            EXECUTIVE SUMMARY 41

FIGURE 10         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)            41

FIGURE 11         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)     42

FIGURE 12         GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET        42

4            PREMIUM INSIGHTS      44

4.1         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW  44

FIGURE 13         RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET         44

4.2         ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022)           45

FIGURE 14         COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022           45

4.3         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       46

FIGURE 15         CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       46

4.4         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX              46

FIGURE 16         ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD     46

4.5         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES            47

FIGURE 17         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD     47

5            MARKET OVERVIEW     48

5.1         INTRODUCTION            48

5.2         MARKET DYNAMICS     48

FIGURE 18         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       48

5.2.1      DRIVERS            49

5.2.1.1   Rising population and increasing prevalence of chronic and infectious diseases              49

5.2.1.2   Increasing number of surgical procedures      49

5.2.1.3   Rising number of hypothermia cases 50

5.2.1.4   Growing number of trauma cases     50

5.2.1.5   Rising adoption of minimally invasive cooling methods 51

5.2.1.6   Growing demand for targeted temperature management in cardiac arrest 51

5.2.2      RESTRAINTS     51

5.2.2.1   Lack of awareness regarding therapeutic hypothermia systems in developing countries              51

5.2.2.2   Availability of alternative methods   52

5.2.3      OPPORTUNITIES           52

5.2.3.1   Increasing growth opportunities in emerging economies            52

5.2.3.2   Developing healthcare infrastructure             53

5.2.3.3   Growing number of contracts and agreements between market players    53

5.2.4      CHALLENGES   54

5.2.4.1   Lack of skilled healthcare professionals          54

5.2.4.2   Lack of proper supply chain management      54

5.2.4.3   Product recalls     55

5.3         VALUE CHAIN ANALYSIS            55

FIGURE 19         VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE         55

5.4         SUPPLY CHAIN ANALYSIS          56

FIGURE 20         DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES      57

5.5         PORTER’S FIVE FORCES ANALYSIS         57

TABLE 3             PORTER’S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET        57

5.5.1      INTENSITY OF COMPETITIVE RIVALRY 57

5.5.2      BARGAINING POWER OF SUPPLIERS     57

5.5.3      BARGAINING POWER OF BUYERS           58

5.5.4      THREAT OF SUBSTITUTES         58

5.5.5      THREAT OF NEW ENTRANTS    58

5.6         REGULATORY ANALYSIS            58

TABLE 4             INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS  58

5.6.1      NORTH AMERICA          59

5.6.1.1   US         59

TABLE 5             CLASSIFICATION OF MEDICAL DEVICES BY US FDA       59

FIGURE 21         PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES            60

5.6.1.2   Canada  60

FIGURE 22         CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES 60

5.6.2      EUROPE             61

FIGURE 23         CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS           61

5.6.3      ASIA PACIFIC    61

5.6.3.1   Japan     61

TABLE 6             JAPAN: CLASSIFICATION OF MEDICAL DEVICES             62

5.6.3.2   China     62

TABLE 7             NMPA MEDICAL DEVICES CLASSIFICATION       62

5.6.3.3   India      63

5.7         TRADE ANALYSIS          63

5.7.1      TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS              63

TABLE 8             IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 63

TABLE 9             EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 63

5.8         TECHNOLOGY ANALYSIS           64

5.9         ECOSYSTEM ANALYSIS 65

FIGURE 24         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS 65

5.9.1      ROLE IN ECOSYSTEM    65

FIGURE 25         KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM     66

5.10       PATENT ANALYSIS        67

FIGURE 26         PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS           67

5.11       KEY CONFERENCES AND EVENTS IN 2024–2025 68

TABLE 10           LIST OF CONFERENCES AND EVENTS IN 2024–2025        68

5.12       PRICING ANALYSIS        70

TABLE 11           AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019–2022)  70

TABLE 12           AVERAGE SELLING PRICE TRENDS, BY REGION, 2019–2022              70

5.13       TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     71

5.13.1    REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS       71

FIGURE 27         REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS              71

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    72

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         72

FIGURE 28         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS       72

TABLE 13           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS       72

5.14.2    BUYING CRITERIA         73

FIGURE 29         KEY BUYING CRITERIA FOR TOP END USERS     73

TABLE 14           KEY BUYING CRITERIA, BY TOP END USER         73

6            THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT              74

6.1         INTRODUCTION            75

TABLE 15           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   75

6.2         COOLING DEVICES       75

6.2.1      INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND           75

TABLE 16           THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)  76

TABLE 17           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)      76

TABLE 18           EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         77

TABLE 19           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)      77

TABLE 20           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)     78

6.3         COOLING CATHETERS 78

6.3.1      ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH        78

TABLE 21           THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)            78

TABLE 22           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79

TABLE 23           EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79

TABLE 24           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80

TABLE 25           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)              80

6.4         COOL CAPS       80

6.4.1      INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND           80

TABLE 26           THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)       81

TABLE 27           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         81

TABLE 28           EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            82

TABLE 29           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         82

TABLE 30           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)  83

7            THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION              84

7.1         INTRODUCTION            85

TABLE 31           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           85

7.2         NEUROLOGY    85

7.2.1      GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET   85

TABLE 32           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)    86

TABLE 33           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)    86

TABLE 34           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)      86

TABLE 35           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)    87

TABLE 36           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)              87

7.3         CARDIOLOGY  87

7.3.1      HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH          87

TABLE 37           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)   88

TABLE 38           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)  88

TABLE 39           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)     89

TABLE 40           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)  89

TABLE 41           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)              90

7.4         NEONATAL CARE          90

7.4.1      INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH          90

TABLE 42           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)           91

TABLE 43           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)              91

TABLE 44           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)            91

TABLE 45           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)              92

TABLE 46           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)          92

7.5         OTHER APPLICATIONS 92

TABLE 47           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 93

TABLE 48           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              93

TABLE 49           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)   94

TABLE 50           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              94

TABLE 51           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)          95

8            THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION 96

8.1         INTRODUCTION            97

TABLE 52           THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)          97

8.2         NORTH AMERICA          98

FIGURE 30         NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT     98

8.2.1      NORTH AMERICA: RECESSION IMPACT 99

TABLE 53           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         99

TABLE 54           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        99

TABLE 55           NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  100

8.2.2      US         100

8.2.2.1   Growing number of cardiac arrest and brain injury cases to support market growth              100

TABLE 56           US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   101

TABLE 57           US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           101

TABLE 58           US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  102

8.2.3      CANADA            102

8.2.3.1   Increasing incidence of various chronic diseases to drive market 102

TABLE 59           CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            103

TABLE 60           CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     103

8.3         EUROPE             104

8.3.1      EUROPE: RECESSION IMPACT   104

TABLE 61           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            104

TABLE 62           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            105

TABLE 63           EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     105

8.3.2      GERMANY         105

8.3.2.1   High demand for patient cooling devices for cardiology procedures to drive market              105

TABLE 64           GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            106

TABLE 65           GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     106

TABLE 66           GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  106

8.3.3      UK         107

8.3.3.1   Rising number of sports injuries and accident & emergency procedures to drive market   107

TABLE 67           UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   107

TABLE 68           UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           108

TABLE 69           UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  108

8.3.4      FRANCE             108

8.3.4.1   Strong healthcare system to support market growth     108

TABLE 70           FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   109

TABLE 71           FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           109

TABLE 72           FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  110

8.3.5      ITALY   110

8.3.5.1   Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth 110

TABLE 73           ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   110

TABLE 74           ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           111

8.3.6      SPAIN   111

8.3.6.1   Growing geriatric population and subsequent increase in prevalence of target conditions to drive market 111

TABLE 75           SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   112

TABLE 76           SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           112

8.3.7      REST OF EUROPE           112

TABLE 77           REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        113

TABLE 78           REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  113

8.4         ASIA PACIFIC    114

FIGURE 31         ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT     114

8.4.1      ASIA PACIFIC: RECESSION IMPACT        115

TABLE 79           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         115

TABLE 80           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        115

TABLE 81           ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  116

8.4.2      CHINA  116

8.4.2.1   Increasing disposable income of middle-class population to drive market 116

TABLE 82           CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   117

TABLE 83           CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           117

TABLE 84           CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  117

8.4.3      JAPAN  118

8.4.3.1   Rapidly increasing geriatric population to drive market 118

TABLE 85           JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   118

TABLE 86           JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           119

TABLE 87           JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)  119

8.4.4      INDIA   119

8.4.4.1   Growing target patient population to support market growth     119

TABLE 88           INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   120

TABLE 89           INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           120

8.4.5      REST OF ASIA PACIFIC  120

TABLE 90           REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     121

TABLE 91           REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)             122

8.5         REST OF THE WORLD   122

8.5.1      REST OF THE WORLD: RECESSION IMPACT       122

TABLE 92           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)         123

TABLE 93           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     123

TABLE 94           REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)             123

8.5.2      LATIN AMERICA             124

8.5.2.1   Rising prevalence of chronic diseases to drive market   124

TABLE 95           LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        124

TABLE 96           LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  125

8.5.3      MIDDLE EAST & AFRICA             125

8.5.3.1   High prevalence of chronic conditions to support market growth             125

TABLE 97           MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     125

TABLE 98           MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)             126

8.5.4      GCC COUNTRIES           126

8.5.4.1   Rise in road accident injuries and TBI to drive market 126

TABLE 99           GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        126

TABLE 100         GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  127

9            COMPETITIVE LANDSCAPE       128

9.1         OVERVIEW        128

9.2         STRATEGIES ADOPTED BY KEY PLAYERS           128

TABLE 101         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET         128

9.3         REVENUE ANALYSIS      129

FIGURE 32         REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, 2018–2022 (USD MILLION)   129

9.4         MARKET SHARE ANALYSIS         130

FIGURE 33         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER (2022)           130

TABLE 102         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEGREE OF COMPETITION 130

9.5         COMPANY EVALUATION MATRIX          131

9.5.1      STARS  131

9.5.2      EMERGING LEADERS    131

9.5.3      PERVASIVE PLAYERS     131

9.5.4      PARTICIPANTS 131

FIGURE 34         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2022      132

9.5.5      COMPANY FOOTPRINT 133

TABLE 103         PRODUCT FOOTPRINT (11 PLAYERS)   133

TABLE 104         REGIONAL FOOTPRINT (11 PLAYERS)   133

TABLE 105         OVERALL COMPANY FOOTPRINT (11 PLAYERS)             134

9.6         STARTUP/SME EVALUATION MATRIX   135

9.6.1      PROGRESSIVE COMPANIES       135

9.6.2      STARTING BLOCKS       135

9.6.3      RESPONSIVE COMPANIES          135

9.6.4      DYNAMIC COMPANIES 135

FIGURE 35         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: STARTUP/SME EVALUATION MATRIX, 2022       136

9.6.5      COMPETITIVE BENCHMARKING            137

TABLE 106         THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES  137

TABLE 107         PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)  137

TABLE 108         REGIONAL FOOTPRINT (STARTUPS/SMES)       138

TABLE 109         OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)    138

9.7         COMPETITIVE SCENARIO AND TRENDS             139

9.7.1      DEALS  139

TABLE 110         THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020–NOVEMBER 2023   139

9.7.2      OTHER DEVELOPMENTS           140

TABLE 111         THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023         140

10          COMPANY PROFILES    141

10.1       KEY PLAYERS   141

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

10.1.1    ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION) 141

TABLE 112         ASAHI KASEI CORPORATION: BUSINESS OVERVIEW       141

FIGURE 36         ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)              142

10.1.2    BECTON, DICKINSON AND COMPANY  144

TABLE 113         BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW              144

FIGURE 37         BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)   145

10.1.3    GENTHERM INCORPORATED   147

TABLE 114         GENTHERM INCORPORATED: BUSINESS OVERVIEW     147

FIGURE 38         GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022)              148

10.1.4    STRYKER CORPORATION           150

TABLE 115         STRYKER CORPORATION: BUSINESS OVERVIEW             150

FIGURE 39         STRYKER CORPORATION: COMPANY SNAPSHOT (2022)              151

10.1.5    BELMONT MEDICAL TECHNOLOGIES  153

TABLE 116         BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW              153

10.1.6    INTERNATIONAL BIOMEDICAL LTD.    154

TABLE 117         INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW              154

10.1.7    EM-MED            155

TABLE 118         EM-MED: BUSINESS OVERVIEW 155

10.1.8    PHOENIX MEDICAL SYSTEMS   156

TABLE 119         PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW      156

10.1.9    LIFE RECOVERY SYSTEMS          157

TABLE 120         LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW            157

10.1.10  SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.             158

TABLE 121         SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW    158

10.1.11  MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.) 159

TABLE 122         MIRACRADLE: BUSINESS OVERVIEW     159

10.2       OTHER PLAYERS           160

10.2.1    TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 160

TABLE 123         TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW  160

10.2.2    PFM MEDICAL HICO GMBH       161

TABLE 124         PFM MEDICAL HICO GMBH: COMPANY OVERVIEW       161

10.2.3    VNG MEDICAL INNOVATION SYSTEM PVT. LTD.            161

TABLE 125         VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW        161

10.2.4    ASPEN SYSTEMS            162

TABLE 126         ASPEN SYSTEMS: COMPANY OVERVIEW             162

10.2.5    COOLTECH MEDICAL  162

TABLE 127         COOLTECH MEDICAL: COMPANY OVERVIEW   162

10.2.6    GLOBAL HEALTHCARE SG         163

TABLE 128         GLOBAL HEALTHCARE SG: COMPANY OVERVIEW         163

10.2.7    CRYOTHERMIC SYSTEMS INCORPORATED        163

TABLE 129         CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW        163

10.2.8    PAXMAN COOLERS LTD.            164

TABLE 130         PAXMAN COOLERS LTD.: COMPANY OVERVIEW             164

10.2.9    DIGNITANA AB 164

TABLE 131         DIGNITANA AB: COMPANY OVERVIEW 164

10.2.10  WISHCAPS         165

TABLE 132         WISHCAPS: COMPANY OVERVIEW         165

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

11          APPENDIX         166

11.1       DISCUSSION GUIDE      166

11.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             170

11.3       CUSTOMIZATION OPTIONS      172

11.4       RELATED REPORTS       172

11.5       AUTHOR DETAILS         173